Recce Pharmaceuticals (RCE) has been granted ethics approval to start a phase one/two study on patients with infected burn wounds sponsored by WA’s South Metropolitan Health Service with Fiona Stanley Hospital as the study site.
Read the full article on The Market Herald.
Recce Pharmaceuticals (ASX:RCE) gains ethics approval to start burns study
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$2.56 |
Change
-0.030(1.16%) |
Mkt cap ! $268.4M | |||
| Open | High | Low | Value | Volume |
| $2.60 | $2.61 | $2.50 | $10.59K | 4.143K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 400 | $2.49 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.98 | 1250 | 1 |
View Market Depth
| Last trade - 12.30pm 29/07/2025 (20 minute delay) ? |
| AFP (ASX) Chart |